Warby Parker Inc.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: Warby Parker Inc.
Former names: JAND, Inc.
Ownership: Public
Status: Active
SIC code: 3851 — Ophthalmic Goods
Jurisdiction of incorporation: Delaware
Headquarters city: New York
Headquarters state / province: New York
Headquarters country: United States
Fiscal year end: December
Ticker symbol: WRBY
Primary stock exchange: NYSE

Identifiers

SEC CIK: 0001504776
EIN: 80-0423634

Board of directors

Follow this board

Andrew Hunt · Director
Since 2023
Bradley E. Singer · Director
Since 2024
David Abraham Gilboa · Director · Co-Chief Executive Officer
Since 2023
Gabrielle Sulzberger · Director
Since 2023
Jeffrey Jacob Raider · Director
Since 2023
Joel E. Cutler · Director
Since 2025
Neil Harris Blumenthal · Director · Co-Chief Executive Officer
Since 2023
Ronald A. Williams · Director
Since 2023
Teresa Briggs · Director
Since 2023
Youngme E. Moon · Director
Since 2023

Chief executives

Neil Harris Blumenthal · Co-Chief Executive Officer

Dates unknown

David Abraham Gilboa · Co-Chief Executive Officer

Dates unknown

Director election results

Annual meeting of June 10, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

6 of this board's directors also sit on 10 other boards.

Shared director Other board Same sector

Sweetgreen Inc.
via Bradley E. Singer, Neil Harris Blumenthal and Youngme E. Moon
Mastercard Incorporated
via Gabrielle Sulzberger and Youngme E. Moon
Crown Castle Inc.
via Bradley E. Singer
DocuSign Inc.
via Teresa Briggs
Eli Lilly and Company
via Gabrielle Sulzberger
ServiceNow Inc.
via Teresa Briggs
Smartbird Inc.
via Neil Harris Blumenthal
Snowflake Inc.
via Teresa Briggs
The Boeing Company
via Ronald A. Williams
agilon health inc.
via Ronald A. Williams

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $0; 0 purchases by 0 insiders
Sold, last 12 months: $50,532,293; 34 sales by 7 insiders

Date	Insider	Transaction	Shares	Price	Value
Sep 2, 2026	Neil Harris Blumenthal Director, Officer (Co-Chief Executive Officer)	Option exercise	+9,815	—	—
Sep 2, 2026	David Abraham Gilboa Director, Officer (Co-Chief Executive Officer)	Option exercise	+9,815	—	—
Sep 2, 2026	Neil Harris Blumenthal Director, Officer (Co-Chief Executive Officer)	Option exercise	+10,983	—	—
Sep 2, 2026	David Abraham Gilboa Director, Officer (Co-Chief Executive Officer)	Option exercise	+10,983	—	—
Sep 2, 2026	Neil Harris Blumenthal Director, Officer (Co-Chief Executive Officer)	Shares withheld for tax	−11,504	$24.19	$278,282
Sep 2, 2026	David Abraham Gilboa Director, Officer (Co-Chief Executive Officer)	Shares withheld for tax	−11,504	$24.19	$278,282
Jul 6, 2026	Neil Harris Blumenthal Director, Officer (Co-Chief Executive Officer)	Derivative conversion	+9,200	—	—
Jul 6, 2026	David Abraham Gilboa Director, Officer (Co-Chief Executive Officer)	Derivative conversion	+54,347	—	—
Jul 6, 2026	Neil Harris Blumenthal Director, Officer (Co-Chief Executive Officer)	Open-market sale	−9,200	$29.99	$275,908
Jul 6, 2026	David Abraham Gilboa Director, Officer (Co-Chief Executive Officer)	Open-market sale	−54,347	$29.84	$1,621,714
Jul 1, 2026	Neil Harris Blumenthal Director, Officer (Co-Chief Executive Officer)	Derivative conversion	+189,320	—	—
Jul 1, 2026	David Abraham Gilboa Director, Officer (Co-Chief Executive Officer)	Derivative conversion	+213,746	—	—
Jul 1, 2026	Jeffrey Jacob Raider Director	Open-market sale	−22,500	$29.72	$668,700
Jul 1, 2026	Neil Harris Blumenthal Director, Officer (Co-Chief Executive Officer)	Open-market sale	−217,667	$29.61	$6,445,120
Jul 1, 2026	David Abraham Gilboa Director, Officer (Co-Chief Executive Officer)	Open-market sale	−242,221	$29.69	$7,191,541

Reviews (0)

No reviews yet. Be the first to write one.